BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 18 | 157↑782.4% | 271↑72.3% | 331↑22.4% | 451↑36.0% |
| Gross Profit | 16 | 150↑829.0% | 264↑76.3% | 327↑23.7% | 438↑34.1% |
| Operating Income | -175 | -178↓1.7% | -148↑16.5% | -104↑30.1% | -3↑97.5% |
| Net Income | -183 | -184↓0.7% | -247↓34.3% | -227↑8.3% | -89↑60.8% |
| EBITDA | -168 | -122↑27.3% | -144↓18.2% | -116↑19.1% | 13↑111.0% |
| EPS Diluted | -1.09 | -1.03↑5.5% | -1.33↓29.1% | -1.18↑11.3% | -0.43↑63.6% |